To investigate associations between sarcopenia, obesity, and sarcopenic obesity and incidence of falls in a racially and ethnically diverse cohort of healthy postmenopausal women. DESIGN: Prospective cohort study. SETTING: Three Women's Health Initiative (WHI) clinical centers (Tucson-Phoenix, AZ; Pittsburgh, PA; Birmingham, AL). PARTICIPANTS: Postmenopausal women aged 50 to 79 enrolled in the WHI who underwent bone and body composition scans using dual-energy x-ray absorptiometry at baseline (N = 11,020). MEASUREMENTS: Sarcopenia was defined as the lowest 20 th percentile of appendicular lean mass, correcting for height and body fat. Obesity was defined as a body fat percentage greater than 42%. Sarcopenic obesity was defined as co-occurrence of sarcopenia and obesity. The fall outcome was defined as falling 2 or more times in any year during 7 years of follow-up. The risk of falls associated with sarcopenic obesity were analyzed using log binomial regression models stratified according to age and race/ ethnicity. RESULTS: Sarcopenic obesity was associated with greater risk of falls in women aged 50 to 64 (relative risk (RR) = 1.35, 95% confidence interval (CI)=1.17-1.56) and 65 to 79 (RR = 1.21, 95% CI=1.05-1.39). Sarcopenic obesity related fall risk was higher in Hispanic women (RR = 2.40, 95% CI=1.56-3.67) than non-Hispanic white women (RR = 1.24, 95% CI=1.11-1.39). CONCLUSION: In a multiethnic cohort of postmenopausal women, sarcopenic obesity-related fall risk was high in women younger than 65 and those age 65 and older. Sarcopenic obesity posed the highest risk for falls in Hispanic women. The findings support identification of causal factors and health disparities in sarcopenic obesity to customize fall prevention strategies and ameliorate this significant public health burden. J Am Geriatr Soc 66:2314-2320, 2018.
T he U.S. population is aging rapidly, with 1 in 5 Americans projected to be aged 65 and older by 2030. 1 The incidence of falls and associated health complications is rising steadily in older adults. 2 It is estimated that approximately two-thirds of all hospital costs ($34 billion) are directly or indirectly associated with unintended falls in older adults who are hospitalized after a fall. 3 Fall-related injuries mainly consist of fractures. 2 Costs associated with fractures are projected to increase disproportionately in nonwhite groups, with an increase in costs of 175% in Hispanics by 2025, versus 37% increase in whites. 4 A better understanding of health disparities in fall risk is imperative to ameliorate the increasing fracture burden in nonwhite groups and in a rapidly aging population.
The accumulating burden of obesity and sarcopenia in the aging population is an important factor driving healthcare needs related to falls and fractures. 5 Sarcopenia is characterized as a progressive, age-associated decline in skeletal muscle mass, muscle strength, and function. Current estimates suggest that 5% to 13% of adults aged 60 and older are considered sarcopenic, with prevalence rates thought to be as high as 50% in adults aged 80 and older. 6 Concomitant with age-related declines in skeletal muscle mass, gains in adiposity, and consequently obesity, may further influence the relationship between sarcopenia and falls risk. Obesity is a growing epidemic, with more than one-third of adults aged 65 and older considered obese in 2010. 7 The combination of sarcopenia and obesity, called "sarcopenic obesity," has been associated with declining physical function and mobility and greater risk of fractures. [8] [9] [10] Studies with differing populations and inconsistent definitions of sarcopenic obesity have produced a wide range of prevalence estimates (0-41%). 11 Clinically, sarcopenia may be masked and be undiagnosed in older adults, particularly if total body weight or body mass index is above normal. 12 The national obesity epidemic coupled with sarcopenia in an aging population has created a circumstance in which fall risk factors are increasing and suggests a need to recognize sarcopenic obesity as a public health priority. Identifying those at greatest risk for sarcopenic obesity related falls is critical to target intervention strategies, such as diet and exercise programs that have been shown to reduce loss of muscle mass during weight loss. 13 Few studies have prospectively investigated the association between sarcopenic obesity and falls, and the prospective association has not been examined in women. 10 Additionally, most studies evaluate falls and predisposing factors, such as loss of muscle mass, in adults aged 65 and older. The Women's Health Initiative (WHI) cohort afforded an opportunity to evaluate fall risk prospectively in a multiethnic cohort across a broader age range than is typically available in the literature and to evaluate the contributions of obesity, sarcopenia, and the combination of the two in women. The primary objectives of this study were to evaluate prospective associations between sarcopenia alone, obesity alone, and concurrent sarcopenic obesity and self-reported falls in postmenopausal women; whether sarcopenic obesity with fall risk differs according to age; and whether sarcopenic obesity with fall risk differs according to race and ethnicity. We hypothesized that sarcopenic obesity would be associated with more falls than sarcopenia alone, obesity alone, or neither, and that sarcopenic obesity-associated falls would differ according to race/ethnic, and age groups.
METHODS

Study Participants
The WHI is a prospective study composed of three clinical trials (low-fat diet patterns, hormone replacement therapy, vitamin D and calcium supplementation) and an observational study.
14 A racially and ethnically diverse cohort of postmenopausal women was recruited from 40 clinic centers throughout the United States between 1993 and 1998 using mass mailings as the primary recruitment method. The WHI enrolled 161,808 multiethnic postmenopausal women aged 50 to 79 with a predicted survival of 3 years or more at baseline. 15 Additional eligibility criteria included ability and an agreement to reside in the area for at least 3 years after enrollment. All WHI participants provided written informed consent, and the institutional review board at each clinic site approved the study. The WHI study design and recruitment have been previously described.
14, 15 The current study included 11,020 participants (n = 4,655 from the clinical trials, n = 6,365 from the observational study) from Tucson-Phoenix, Arizona; Pittsburgh, Pennsylvania; and Birmingham, Alabama who underwent dual-energy x-ray absorptiometry (DXA) scans at baseline. We excluded participants with missing sarcopenia data and those missing more than half of fall data in 7 years of follow-up.
Sarcopenia and Obesity
The primary exposure variable had the following categories defined at baseline: sarcopenic only, obese only, sarcopenic and obese, neither sarcopenic nor obese. Trained technicians determined obesity and sarcopenia using whole-body DXA scans (QDR2000, 2000+, or 4500 W, Hologic Inc., Bedford, MA). Obesity was classified as body fat percentage of 42% or greater, as recommended for women aged 60 to 79, the category most closely corresponding to the WHI population. 16 Following a previous WHI study, we defined sarcopenia using the residual method because it has been shown to have strong correlations with lower extremity function. 17, 18 Sarcopenia was defined as the lowest 20 th percentile of appendicular lean mass, accounting for height and body fat. Height was measured to the nearest 0.1 cm using a wall-mounted stadiometer.
Covariates
Information was collected on covariates including age, race, ethnicity, smoking status, alcohol use, income, weekly physical activity, general health, hormone use, and number of falls in the last 12 months using self-reported questionnaires at baseline. 15 Missing covariate data were assessed for type of missingness and imputed using the mean. A sensitivity analysis was used to determine whether imputed covariate data changed the results of the analysis.
Falls
Falls were assessed using a self-report medical history questionnaire administered annually in observational study participants and semiannually in clinical trial participants with the question: "During the past 12 months, how many times did you fall and land on the floor or ground (do not include falls due to sports activities such as snow-or water-skiing or horseback riding)?" 19 Possible answers included 0, 1, 2, and 3 or more times. Falls were included from follow-up years 1 through 7. Two or more falls per year is a strong predictor of fall risk, consistent with prior WHI studies, 20-22 so we categorized falls as a binary variable: 1 or fewer (nonfaller) versus 2 or more falls (faller) in any year of follow-up.
Statistical Approach
Baseline characteristics were compared according to fall status (faller vs nonfaller). Categorical variables were compared using the chi-square test, and continuous variable means were compared using the Student t-test. We analyzed JAGS DECEMBER 2018-VOL. 66, NO. 12 SARCOPENIC OBESITY AND FALLSbody composition (sarcopenic, obese, sarcopenic obese, neither sarcopenic nor obese) as the independent variable in log binomial regression models to estimate relative risks (RRs) and 95% confidence intervals (95% CIs) of falls. Adjustment for covariates was considered for any measure or characteristic or reported clinical or medical factor present at baseline that might confound the relationship between sarcopenia and falls as supported by the literature (age, race, ethnicity, smoking status, alcohol use, income, weekly physical activity, general self-reported health, hormone replacement therapy use, number of falls in 12 months before baseline, clinical trial arm, DXA serial number) and added to the model using purposeful selection. 23 Model covariates were retained if they were considered important in the literature or their addition resulted in a change in RR of 10% or greater. Models were subsequently stratified to examine potential effect modification according to age and race/ethnicity, defined as a 10% or greater difference in stratified RR values. We stratified age at 65 at baseline to be consistent with fall literature showing that adults aged 65 and older are at higher risk of falls. 2 The most parsimonious model is presented. Two-sided P-values less than .05 were considered significant. Statistical analyses were performed using SAS version 9.4 (SAS Institute, Inc., Cary, NC).
RESULTS
Baseline Characteristics
The analytical sample consisted of 9,924 women after excluding 436 with missing sarcopenia data and 660 missing more than half of fall data in 7 years of follow-up ( Figure 1 ). Missing covariate data were imputed using the mean. Women aged 65 to 79 at baseline were more likely to fall than those aged 50 to 64 (Table 1) . Fallers were more likely to be non-Hispanic white and Native American or Alaskan Native than black or Hispanic. Fallers had a higher percentage of whole body fat and lower levels of physical activity and were more likely to report 2 or more falls in the 12 months before baseline.
The prevalence of sarcopenia was similar in nonHispanic white, Hispanic, and Native American and Alaska Native women (4%, 3%, and 3%, respectively [ Figure 2 ]). Black women had the lowest prevalence of sarcopenia at 0.3%, but the highest prevalence of obesity at 65%. Prevalence of sarcopenic obesity was highest in Native American or Alaska Native women (30%), lowest in black women (7%), and similar in non-Hispanic white (19%) and Hispanic women (18%).
Age Findings
Age and race/ethnicity were effect modifiers in the association between body composition and falls, so analyses were stratified according to these factors. Table 2 presents the crude and adjusted RR and 95% CI for the association between falls and each body composition measure (sarcopenia, obesity, sarcopenic obesity) stratified according to age at baseline. In women aged 50 to 64 at baseline, all body composition categories were associated with greater risk of falling than not sarcopenic or obese. In women aged 65 to 79 at baseline, obesity and sarcopenic obesity, but not sarcopenia alone, were associated with greater risk of falling. Fall risk associated with sarcopenic obesity was stronger in the younger (RR = 1.35, 95% CI=1.17-1.56) than the older group (RR = 1.21, 95% CI=1.05-1.39). Table 3 presents the crude and adjusted RRs for the association between body composition and falls stratified according to race and ethnicity. After adjusting for age, smoking status, alcohol use, physical activity, and hormone use, sarcopenia alone was not a significant predictor of falls in any racial or ethnic group (Table 3) . Sarcopenia could not be evaluated for black women because it was far less prevalent (0.3%) (Figure 2 ). Obesity in black women was associated with a risk of falling that was 1.19 (95% CI=0.95-1.50) times as great as in black women with neither condition. Obesity was a statistically significant predictor of falls in non-Hispanic white women (RR = 1.17, 95% CI=1.07-1.29) and Hispanic women (RR = 1.57, 95% CI=1.06-2.34). Sarcopenic obesity was a significant predictor of falls in Hispanic (RR = 2.40, 95% CI=1.56-3.67) and non-Hispanic white (RR = 1.24, 95% CI=1.11-1.39) women.
Race/Ethnicity Findings
DISCUSSION
Race/Ethnicity Findings
This is the first study to our knowledge to assess differences in sarcopenic obesity related falls according to race and ethnicity. Race represents the embodiment of a social classification system "structuring opportunity and assigning value based on phenotype." 24, 25 Ethnicity reflects social classification within a shared culture, Hispanic or non-Hispanic. 26 The results of this study indicate that sarcopenic obesity may result in significantly greater risk of falling in Hispanic than non-Hispanic white postmenopausal women. Sarcopenic obesity was the strongest risk factor for falls, suggesting that co-occurrence increases fall risk over that of each condition separately. This result is consistent with a prior study in older white women in the New Mexico Aging Process Study, which found that sarcopenic obesity increased the risk of falls more than either condition alone or neither condition. 5 In contrast, a study in a Tasmanian cohort found dynapenic (low muscle strength) obesity but not sarcopenic (low muscle mass) obesity was associated with greater fall risk. 27 Obesity alone increased the risk of falls in Hispanic and non-Hispanic white women, but sarcopenia in nonobese women was not associated with falls in any racial or ethnic group. The low prevalence of sarcopenia in nonobese women reported in our study is consistent with crosssectional results from the National Health and Nutrition Examination Surveys (NHANES) cohort; investigators also noted that sarcopenia alone was associated with physical limitations in older adults. 28 In black and Native American and Alaskan Native women, results of our study showed no statistically significant difference in falls according to body composition group. Black women had the lowest prevalence of sarcopenia and sarcopenic obesity, in agreement with the weighted prevalence from the NHANES cohort. 28, 29 Native American and Alaskan Native women, who are traditionally excluded from large cohort studies, had the highest prevalence of sarcopenic obesity and falls, although the small sample sizes of these racial and ethnic groups and hence insufficient power warrants further investigation.
Obesity may be a mechanism promoting sarcopenia and increasing fall risk through balance destabilization. 30 A recent study showed that sarcopenic obese individuals had more risk factors for falls and fractures, including poor balance, high serum parathyroid hormone levels, and low vitamin D levels. 31 Visceral fat in the abdominal region has been shown to degrade bone by increasing proinflammatory factors. 32 The deleterious effects of visceral fat-related inflammation promotes sarcopenia through muscle degradation. 33 Racial and ethnic differences in fall risk from sarcopenic obesity may relate to differences in abdominal and general obesity because Hispanic women are more likely to accumulate abdominal fat than white women. 34, 35 Overall, this study is consistent with prior literature indicating the synergistic effect of low muscle mass and obesity on falls and contributes to a race-and ethnicity-specific analysis of this association. 10, 31 Determining fall risk factors specific to Hispanic, black, and Native American and Alaskan Native women in the United States is critical to addressing the disproportionately increasing burden of fractures in these communities. 36 Fracture rates are higher in whites, but rates are quickly increasing in nonwhites, with an expected increase from 12% in 2012 to 21% in 2025. 4 In addition, mortality after hip fractures is higher in nonwhites and may be related to treatment disparities such as delayed preoperative wait time to surgery after hip fracture in blacks and Hispanics. 37, 38 Evaluating and treating sarcopenic obesity is imperative to reduce falls, a leading cause of fractures, particularly in Hispanic women. 39 Our study suggests that clinical evaluation of sarcopenia in postmenopausal women is particularly important in fall prevention for obese Hispanic women. More research is needed to understand racial and ethnic differences in sarcopenic obesity-related fall risk, particularly in Native American and Alaskan Natives.
Age Findings
Adults aged 65 and older are at higher risk of falls than those younger than 65, and most research on sarcopenic obesity has focused on subjects aged 60 and older. 2, 11 This study shows that, in women aged 50 to 64 at baseline, sarcopenia and sarcopenic obesity are associated with fall risk. The prevalence of sarcopenic obesity increased with age, in agreement with NHANES data in adults aged 60 and older. 28 Nevertheless, younger women were at slightly higher risk of falls associated with sarcopenic obesity and sarcopenia, despite a lower overall fall rate. Fall risk increases with accumulating number of predictors, so falls in older women may be better explained using a model accounting for a cluster of aging-related conditions, including sarcopenic obesity combined with other comorbid conditions such as decline in visual and sensory and motor functions. 40 One such measure is frailty, which considers sarcopenia and age-associated cumulative decline in multiple systems. 41 A previous WHI study found that frailty was more likely in women aged 70 to 79 than in those aged 65 to 69. 42 Nonetheless, future research should be directed at identifying those at high risk of falls, including adults younger than 65, because prior research found a 25% fall prevalence over 2 years in this age group. 43 The current study suggests that sarcopenic obesity should be evaluated in adults younger than 65 to mitigate fall risk.
Strengths and Limitations
These results should be taken with caution because the WHI cohort consists of healthy community-dwelling participants, and thus those most at risk of falls are not represented. The WHI exclusion criteria included institutionalization and dementia, which are each significant risk factors for falls in older adults. 15 Healthy volunteer bias may underestimate sarcopenic obesity-associated fall risk disproportionately in the population aged 65 to 79, which is least likely to be represented in this cohort.
Although strength and physical function have been included in definitions of sarcopenia in recent years, the present study used a historical definition of sarcopenia because the strength and physical function definitions did not exist during the primary WHI study period, and therefore, strength measures were unavailable for this population. Even so, the residual method is a strong predictor of lower extremity function. 18 Participants self-reported falls, which may have been underreported because of recall bias, especially in older women. Data on fall-related injuries were not available. Lastly, the WHI defined race and ethnicity using the census definition of self-identified categories that may serve as proxy measurements for cultural affinity, social stratification, or ancestral origin. 44 Future research using refined measurements should investigate the underlying causal risk factors for racial and ethnic differences. Strengths of this study include its longitudinal design assessing sarcopenic obesity status before the occurrence of prospectively evaluated fall outcomes. It contributes to understanding of sarcopenic obesity-related fall risk by providing racial-, ethnic-, and age-specific results and evaluating a large cohort of postmenopausal women.
CONCLUSION
Sarcopenic obesity posed the highest risk of falls in Hispanic postmenopausal women. Postmenopausal women younger than 65 were at high risk of sarcopenic obesityrelated falls. As the population ages, the growing prevalence of each condition, independently and even more so in synergy, may place many older adults at high risk of falls. Efforts to understand changing body composition after menopause will help inform potential interventions to reduce falls. The results of this study warrant more in-depth research to elucidate racial-, ethnic-, and age-specific sarcopenic obesity prevention strategies to lessen falls as a significant public health threat.
